BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22414628)

  • 1. Nongenomic effects of thyroid hormones on the immune system cells: New targets, old players.
    De Vito P; Balducci V; Leone S; Percario Z; Mangino G; Davis PJ; Davis FB; Affabris E; Luly P; Pedersen JZ; Incerpi S
    Steroids; 2012 Aug; 77(10):988-95. PubMed ID: 22414628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of nongenomic actions of thyroid hormone.
    Davis PJ; Leonard JL; Davis FB
    Front Neuroendocrinol; 2008 May; 29(2):211-8. PubMed ID: 17983645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormones as modulators of immune activities at the cellular level.
    De Vito P; Incerpi S; Pedersen JZ; Luly P; Davis FB; Davis PJ
    Thyroid; 2011 Aug; 21(8):879-90. PubMed ID: 21745103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of thyroid hormones during development: Focus on signal transduction.
    Scapin S; Leoni S; Spagnuolo S; Gnocchi D; De Vito P; Luly P; Pedersen JZ; Incerpi S
    Steroids; 2010; 75(8-9):576-84. PubMed ID: 19900468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
    Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
    Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.
    Davis PJ; Davis FB; Lin HY; Mousa SA; Zhou M; Luidens MK
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1238-46. PubMed ID: 19755667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system.
    Axelband F; Dias J; Ferrão FM; Einicker-Lamas M
    J Cell Physiol; 2011 Jan; 226(1):21-8. PubMed ID: 20658515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping nongenomic and genomic actions of thyroid hormone and steroids.
    Davis PJ; Lin HY; Mousa SA; Luidens MK; Hercbergs AA; Wehling M; Davis FB
    Steroids; 2011 Aug; 76(9):829-33. PubMed ID: 21354437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis of Nongenomic Actions of Thyroid Hormone.
    Davis PJ; Leonard JL; Lin HY; Leinung M; Mousa SA
    Vitam Horm; 2018; 106():67-96. PubMed ID: 29407448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.
    Davis PJ; Davis FB; Lin HY
    Steroids; 2008 Oct; 73(9-10):1013-7. PubMed ID: 18329679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone and angiogenesis.
    Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
    Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of thyroid hormone actions.
    Cheng SY; Leonard JL; Davis PJ
    Endocr Rev; 2010 Apr; 31(2):139-70. PubMed ID: 20051527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
    Davis PJ; Mousa SA; Lin HY
    Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative nongenomic and genomic actions on thyroid hormone mediated-modulation of T cell proliferation involve up-regulation of thyroid hormone receptor and inducible nitric oxide synthase expression.
    Barreiro Arcos ML; Sterle HA; Paulazo MA; Valli E; Klecha AJ; Isse B; Pellizas CG; Farias RN; Cremaschi GA
    J Cell Physiol; 2011 Dec; 226(12):3208-18. PubMed ID: 21344381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones.
    Davis PJ; Tillmann HC; Davis FB; Wehling M
    J Endocrinol Invest; 2002 Apr; 25(4):377-88. PubMed ID: 12030612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone as a regulator of tumor induced angiogenesis.
    Pinto M; Soares P; Ribatti D
    Cancer Lett; 2011 Feb; 301(2):119-26. PubMed ID: 21183275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid: biological actions of 'nonclassical' thyroid hormones.
    Senese R; Cioffi F; de Lange P; Goglia F; Lanni A
    J Endocrinol; 2014 May; 221(2):R1-12. PubMed ID: 24464019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps.
    Lin HY; Tang HY; Davis FB; Mousa SA; Incerpi S; Luidens MK; Meng R; Davis PJ
    Discov Med; 2012 Sep; 14(76):199-206. PubMed ID: 23021374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin.
    Cohen K; Ellis M; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
    Mol Cancer Res; 2011 Oct; 9(10):1385-94. PubMed ID: 21821675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).
    Mousa SS; Davis FB; Davis PJ; Mousa SA
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):288-93. PubMed ID: 19903697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.